Investing.com - Crescent Capital BDC (NASDAQ: CCAP) reported fourth quarter EPS of $0.61, $0.04 better than the analyst estimate of $0.57. Revenue for the quarter came in at $50M versus the consensus estimate of $47.73M.
Crescent Capital BDC's stock price closed at $16.50. It is down -0.78% in the last 3 months and up 11.64% in the last 12 months.
Crescent Capital BDC saw 3 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Crescent Capital BDC's stock price’s past reactions to earnings here.
According to InvestingPro, Crescent Capital BDC's Financial Health score is "great performance".
Check out Crescent Capital BDC's recent earnings performance, and Crescent Capital BDC's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar